• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分化自人尿源干细胞的具有屏障功能的尿路上皮细胞,有望用于尿路重建。

Urothelium with barrier function differentiated from human urine-derived stem cells for potential use in urinary tract reconstruction.

机构信息

Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA.

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, China.

出版信息

Stem Cell Res Ther. 2018 Nov 8;9(1):304. doi: 10.1186/s13287-018-1035-6.

DOI:10.1186/s13287-018-1035-6
PMID:30409188
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6225683/
Abstract

BACKGROUND

Autologous urothelial cells are often obtained via bladder biopsy to generate the bio-engineered urethra or bladder, while urine-derived stem cells (USC) can be obtained by a non-invasive approach. The objective of this study is to develop an optimal strategy for urothelium with permeability barrier properties using human USC which could be used for tissue repair in the urinary tract system.

METHODS

USC were harvested from six healthy adult individuals. To optimize urothelial differentiation, five different differentiation methods were studied. The induced cells were assessed for gene and protein expression markers of urothelial cells via RT-PCR, Western blotting, and immunofluorescent staining. Barrier function and ultrastructure of the tight junction were assessed with permeability assays and transmission electron microscopy (TEM). Induced cells were both cultured on trans-well membranes and small intestinal submucosa, then investigated under histology analysis.

RESULTS

Differentiated USC expressed significantly higher levels of urothelial-specific transcripts and proteins (Uroplakin III and Ia), epithelial cell markers (CK20 and AE1/AE3), and tight junction markers (ZO-1, ZO-2, E-cadherin, and Cingulin) in a time-dependent manner, compared to non-induced USC. In vitro assays using fluorescent dye demonstrated a significant reduction in permeability of differentiated USC. In addition, transmission electron microscopy confirmed appropriate ultrastructure of urothelium differentiated from USC, including tight junction formation between neighboring cells, which was similar to positive controls. Furthermore, multilayered urothelial tissues formed 2 weeks after USC were differentiated on intestine submucosal matrix.

CONCLUSION

The present study illustrates an optimal strategy for the generation of differentiated urothelium from stem cells isolated from the urine. The induced urothelium is phenotypically and functionally like native urothelium and has proposed uses in in vivo urological tissue repair or in vitro urethra or bladder modeling.

摘要

背景

自体尿路上皮细胞通常通过膀胱活检获得,以生成生物工程尿道或膀胱,而尿液来源的干细胞(USC)可以通过非侵入性方法获得。本研究的目的是开发一种使用人 USC 获得具有渗透屏障特性的尿路上皮的最佳策略,该策略可用于泌尿系统的组织修复。

方法

从六名健康成年个体中采集 USC。为了优化尿路上皮分化,研究了五种不同的分化方法。通过 RT-PCR、Western blot 和免疫荧光染色评估诱导细胞的尿路上皮细胞基因和蛋白表达标志物。通过渗透测定法和透射电子显微镜(TEM)评估紧密连接的屏障功能和超微结构。将诱导细胞分别培养在 Transwell 膜和小肠黏膜下层上,然后在组织学分析下进行研究。

结果

与未诱导的 USC 相比,分化的 USC 表达明显更高水平的尿路上皮特异性转录本和蛋白质(Uroplakin III 和 Ia)、上皮细胞标志物(CK20 和 AE1/AE3)和紧密连接标志物(ZO-1、ZO-2、E-cadherin 和 Cingulin),呈时间依赖性。体外荧光染料测定表明,分化的 USC 的渗透能力显著降低。此外,透射电子显微镜证实了从 USC 分化而来的尿路上皮具有适当的超微结构,包括相邻细胞之间紧密连接的形成,与阳性对照相似。此外,在 USC 分化在肠黏膜下层基质上 2 周后,形成了多层尿路上皮组织。

结论

本研究说明了一种从尿液中分离的干细胞生成分化尿路上皮的最佳策略。诱导的尿路上皮在表型和功能上与天然尿路上皮相似,并已被提议用于体内泌尿科组织修复或体外尿道或膀胱建模。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d7d/6225683/9a1b7e1266a0/13287_2018_1035_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d7d/6225683/a0a60d6d070d/13287_2018_1035_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d7d/6225683/cdbe268fb803/13287_2018_1035_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d7d/6225683/c96e7011005c/13287_2018_1035_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d7d/6225683/9a1b7e1266a0/13287_2018_1035_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d7d/6225683/a0a60d6d070d/13287_2018_1035_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d7d/6225683/cdbe268fb803/13287_2018_1035_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d7d/6225683/c96e7011005c/13287_2018_1035_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d7d/6225683/9a1b7e1266a0/13287_2018_1035_Fig5_HTML.jpg

相似文献

1
Urothelium with barrier function differentiated from human urine-derived stem cells for potential use in urinary tract reconstruction.分化自人尿源干细胞的具有屏障功能的尿路上皮细胞,有望用于尿路重建。
Stem Cell Res Ther. 2018 Nov 8;9(1):304. doi: 10.1186/s13287-018-1035-6.
2
Ureter tissue engineering with vessel extracellular matrix and differentiated urine-derived stem cells.输尿管组织工程与血管细胞外基质和分化的尿液来源干细胞。
Acta Biomater. 2019 Apr 1;88:266-279. doi: 10.1016/j.actbio.2019.01.072. Epub 2019 Feb 1.
3
Human urine-derived stem cells seeded in a modified 3D porous small intestinal submucosa scaffold for urethral tissue engineering.人尿源干细胞接种于改良的 3D 多孔小肠黏膜下层支架中用于尿道组织工程。
Biomaterials. 2011 Feb;32(5):1317-26. doi: 10.1016/j.biomaterials.2010.10.006. Epub 2010 Nov 4.
4
Tissue-engineered conduit using urine-derived stem cells seeded bacterial cellulose polymer in urinary reconstruction and diversion.采用尿源干细胞接种于细菌纤维素聚合物构建组织工程导管在尿流改道及重建中的应用。
Biomaterials. 2010 Dec;31(34):8889-901. doi: 10.1016/j.biomaterials.2010.07.108. Epub 2010 Aug 25.
5
Differentiation of human endometrial stem cells into urothelial cells on a three-dimensional nanofibrous silk-collagen scaffold: an autologous cell resource for reconstruction of the urinary bladder wall.人子宫内膜干细胞在三维纳米纤维丝素 - 胶原支架上向尿路上皮细胞的分化:一种用于膀胱壁重建的自体细胞资源。
J Tissue Eng Regen Med. 2015 Nov;9(11):1268-76. doi: 10.1002/term.1632. Epub 2013 Jan 14.
6
Mechanical stimuli-induced urothelial differentiation in a human tissue-engineered tubular genitourinary graft.机械刺激诱导人组织工程管状泌尿生殖移植物中的尿路上皮分化。
Eur Urol. 2011 Dec;60(6):1291-8. doi: 10.1016/j.eururo.2011.05.051. Epub 2011 Jun 12.
7
Characterization of rabbit urine-derived stem cells for potential application in lower urinary tract tissue regeneration.兔尿源干细胞的特性及其在下尿路组织再生中的潜在应用
Cell Tissue Res. 2018 Nov;374(2):303-315. doi: 10.1007/s00441-018-2885-z. Epub 2018 Jul 31.
8
Self-renewal and differentiation capacity of urine-derived stem cells after urine preservation for 24 hours.尿液保存 24 小时后尿液来源干细胞的自我更新和分化能力。
PLoS One. 2013;8(1):e53980. doi: 10.1371/journal.pone.0053980. Epub 2013 Jan 18.
9
Human Urine-Derived Stem Cell Differentiation to Endothelial Cells with Barrier Function and Nitric Oxide Production.人尿源干细胞向具有屏障功能和产生一氧化氮的内皮细胞分化。
Stem Cells Transl Med. 2018 Sep;7(9):686-698. doi: 10.1002/sctm.18-0040. Epub 2018 Jul 16.
10
Differentiation of human adipose-derived stem cells co-cultured with urothelium cell line toward a urothelium-like phenotype in a nude murine model.在裸鼠模型中,人脂肪来源干细胞与尿路上皮细胞系共培养向尿路上皮样表型的分化。
Urology. 2013 Feb;81(2):465.e15-22. doi: 10.1016/j.urology.2012.10.030.

引用本文的文献

1
Challenges of using tissue engineering methods in the treatment of hypospadias.在治疗尿道下裂中使用组织工程方法面临的挑战。
Front Bioeng Biotechnol. 2025 Jul 2;13:1611508. doi: 10.3389/fbioe.2025.1611508. eCollection 2025.
2
Use of adipose-derived stem cells on decellularized bladder scaffolds for functional bladder mucosa regeneration.脂肪来源干细胞在去细胞膀胱支架上用于功能性膀胱黏膜再生的应用。
Stem Cells Transl Med. 2025 Jun 25;14(7). doi: 10.1093/stcltm/szaf033.
3
KRT5 TP63-expressing urothelial basal cells act as a driver to bladder urothelium regeneration in rabbit.

本文引用的文献

1
Differentiate into urothelium and smooth muscle cells from adipose tissue-derived stem cells for ureter reconstruction in a rabbit model.在兔模型中,使脂肪组织来源的干细胞分化为尿路上皮和平滑肌细胞用于输尿管重建。
Am J Transl Res. 2016 Sep 15;8(9):3757-3768. eCollection 2016.
2
Advanced Properties of Urine Derived Stem Cells Compared to Adipose Tissue Derived Stem Cells in Terms of Cell Proliferation, Immune Modulation and Multi Differentiation.与脂肪组织来源的干细胞相比,尿液来源干细胞在细胞增殖、免疫调节和多向分化方面的高级特性
J Korean Med Sci. 2015 Dec;30(12):1764-76. doi: 10.3346/jkms.2015.30.12.1764. Epub 2015 Nov 30.
3
表达KRT5和TP63的尿路上皮基底细胞是家兔膀胱尿路上皮再生的驱动因素。
Stem Cell Res Ther. 2025 Jun 7;16(1):296. doi: 10.1186/s13287-025-04417-z.
4
Urine-derived stem cells: a sustainable resource for advancing personalized medicine and dental regeneration.尿液来源的干细胞:推进个性化医疗和牙齿再生的可持续资源。
Front Bioeng Biotechnol. 2025 Apr 28;13:1571066. doi: 10.3389/fbioe.2025.1571066. eCollection 2025.
5
Exosome-mediated renal protection: Halting the progression of fibrosis.外泌体介导的肾脏保护:阻止纤维化进展。
Genes Dis. 2023 Sep 19;11(6):101117. doi: 10.1016/j.gendis.2023.101117. eCollection 2024 Nov.
6
Comprehensive proteomic characterization of urethral stricture disease in the Chinese population.中国人群尿道狭窄疾病的综合蛋白质组学特征分析
Front Mol Biosci. 2024 Jul 26;11:1401970. doi: 10.3389/fmolb.2024.1401970. eCollection 2024.
7
The potential of organoids in renal cell carcinoma research.类器官在肾细胞癌研究中的潜力。
BMC Urol. 2024 Jun 11;24(1):120. doi: 10.1186/s12894-024-01511-x.
8
Therapeutic potential of urine-derived stem cells in renal regeneration following acute kidney injury: A comparative analysis with mesenchymal stem cells.急性肾损伤后尿源性干细胞在肾脏再生中的治疗潜力:与间充质干细胞的比较分析
World J Stem Cells. 2024 May 26;16(5):525-537. doi: 10.4252/wjsc.v16.i5.525.
9
Adhesion G Protein-Coupled Receptor () Expression Profiling in Diseased Mouse, Rat, and Human Kidneys.黏附 G 蛋白偶联受体()在病变的鼠、大鼠和人肾脏中的表达谱分析。
Cells. 2024 May 18;13(10):874. doi: 10.3390/cells13100874.
10
Urine-derived stem cells: Promising advancements and applications in regenerative medicine and beyond.尿液来源的干细胞:再生医学及其他领域的前景进展与应用
Heliyon. 2024 Mar 10;10(6):e27306. doi: 10.1016/j.heliyon.2024.e27306. eCollection 2024 Mar 30.
Conditioned medium from fresh and demineralized bone enhances osteoclastogenesis in murine bone marrow cultures.
来自新鲜脱矿骨的条件培养基可增强小鼠骨髓培养中的破骨细胞生成。
Clin Oral Implants Res. 2016 Feb;27(2):226-32. doi: 10.1111/clr.12573. Epub 2015 Mar 6.
4
Urine-derived stem cells: A novel and versatile progenitor source for cell-based therapy and regenerative medicine.尿液来源的干细胞:一种用于细胞治疗和再生医学的新型多功能祖细胞来源。
Genes Dis. 2014 Sep 1;1(1):8-17. doi: 10.1016/j.gendis.2014.07.001.
5
Urine-derived stem cells for potential use in bladder repair.用于膀胱修复潜在用途的尿液来源干细胞。
Stem Cell Res Ther. 2014 May 28;5(3):69. doi: 10.1186/scrt458.
6
Generation of bladder urothelium from human pluripotent stem cells under chemically defined serum- and feeder-free system.在化学成分明确的无血清和无饲养层系统下,由人多能干细胞生成膀胱尿路上皮。
Int J Mol Sci. 2014 Apr 25;15(5):7139-57. doi: 10.3390/ijms15057139.
7
Conditioned medium as a strategy for human stem cells chondrogenic differentiation.条件培养基作为人类干细胞软骨分化的一种策略。
J Tissue Eng Regen Med. 2015 Jun;9(6):714-23. doi: 10.1002/term.1812. Epub 2013 Oct 24.
8
The effect of urine-derived stem cells expressing VEGF loaded in collagen hydrogels on myogenesis and innervation following after subcutaneous implantation in nude mice.尿液来源的干细胞表达血管内皮生长因子负载在胶原水凝胶中对裸鼠皮下植入后肌生成和神经支配的影响。
Biomaterials. 2013 Nov;34(34):8617-29. doi: 10.1016/j.biomaterials.2013.07.077. Epub 2013 Aug 9.
9
Multipotential differentiation of human urine-derived stem cells: potential for therapeutic applications in urology.人尿源干细胞的多能性分化:在泌尿科治疗应用中的潜力。
Stem Cells. 2013 Sep;31(9):1840-56. doi: 10.1002/stem.1424.
10
Urothelial signaling.尿路上皮信号转导
Physiol Rev. 2013 Apr;93(2):653-80. doi: 10.1152/physrev.00030.2012.